Entrada Therapeutics, Inc (TRDA) insider trading
Every open-market stock purchase and sale by Entrada Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Kush Parmar (Insider) sold $1.9M in the last 90 days.
- Last insider buy: Bernhardt G Zeiher (Director), $29.3K, 4 months ago.
Last 12 months: insiders bought $1.6M (3 buys) and sold $6.7M (11 sales). Last close $7.17 on Sep 3, 2026.
Recent TRDA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 2, 2026 | Dipal Doshi (CEO) | Sold (not open market) | $62.3K |
| Sep 2, 2026 | Nathan J Dowden (COO) | Sold (not open market) | $18.1K |
| Sep 2, 2026 | Natarajan Sethuraman (President) | Sold (not open market) | $14.9K |
| Sep 2, 2026 | Kory James Wentworth (CFO) | Sold (not open market) | $12.4K |
| Aug 10, 2026 | Kush Parmar (Insider) | Sold | $647K |
| Aug 7, 2026 | Kush Parmar (Insider) | Sold | $358K |
| Aug 6, 2026 | Kush Parmar (Insider) | Sold | $73.5K |
| Jul 31, 2026 | Kush Parmar (Insider) | Sold | $11.8K |
| Jul 30, 2026 | Kush Parmar (Insider) | Sold | $795K |
| Jun 10, 2026 | Bernhardt G Zeiher (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Peter S Kim (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Mary Thistle (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Gina Chapman (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Kush Parmar (10% owner) | Bought (not open market) | — |
| Jun 10, 2026 | Maha Radhakrishnan (Director) | Bought (not open market) | — |
| May 20, 2026 | Bernhardt G Zeiher (Director) | Bought | $29.3K |
| May 4, 2026 | Natarajan Sethuraman (President) | Sold | $399K |
| May 4, 2026 | Nathan J Dowden (COO) | Sold | $230K |
| May 4, 2026 | Nathan J Dowden (COO) | Bought (not open market) | — |
| Apr 1, 2026 | Kory James Wentworth (CFO) | Sold | $32.4K |
| Mar 10, 2026 | Nathan J Dowden (COO) | Sold | $155K |
| Mar 10, 2026 | Kory James Wentworth (CFO) | Sold | $148K |
| Mar 9, 2026 | Kory James Wentworth (CFO) | Sold | $66.2K |
| Mar 9, 2026 | Nathan J Dowden (COO) | Sold | $40.6K |
| Mar 4, 2026 | Kory James Wentworth (CFO) | Sold | $97.9K |
Who's trading TRDA
- Natarajan Sethuraman, President: sold $399K (1 sale), last Sep 2, 2026
- Dipal Doshi, CEO: other filings, last Sep 2, 2026
- Kory James Wentworth, CFO: sold $434K (5 sales), last Sep 2, 2026
- Nathan J Dowden, COO: sold $426K (3 sales), last Sep 2, 2026
- Kush Parmar, Insider: sold $3.6M (6 sales), last Aug 10, 2026
- Peter S Kim, Director: other filings, last Jun 10, 2026
- Gina Chapman, Director: other filings, last Jun 10, 2026
- Mary Thistle, Director: other filings, last Jun 10, 2026
- Bernhardt G Zeiher, Director: bought $29.3K (1 buy), last Jun 10, 2026
- Maha Radhakrishnan, Director: other filings, last Jun 10, 2026
- Baker Bros. Advisors LP, Insider: bought $1.6M (16 buys), last Nov 20, 2025
- 5AM Ventures V L.P., Insider: sold $1.8M (1 sale), last Nov 14, 2025
Get free alerts when an insider at Entrada Therapeutics, Inc files a new trade →